Do-Guk Son
Fortuna: 14 429 $ al 30/09/2026
Fortuna: 14 429 $ al 30/09/2026
Do-Guk Son currently works at HLB bioStep Co., Ltd., as CFO, Director, Managing Director & Head-Finance from 2024 and HLB PANAGENE Co., Ltd., as Director from 2023.
Mr. Son received his undergraduate degree from Seoul National University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
HLB BIOSTEP CO.LTD. 0,03 % | 11/09/2026 | 6.000 ( 0,03 % ) | 14 429 $ | 30/09/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| HLB BIOSTEP CO.,LTD. | Director Financiero/CFO | - |
| HLB PANAGENE CO., LTD. | Director/Miembro de la Junta | 03/08/2023 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
Seoul National University
Seoul National University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
HLB PANAGENE Co., Ltd.
HLB PANAGENE Co., Ltd. Medical SpecialtiesHealth Technology Manufactures diagnostic equipment for DNA testing | Health Technology |
HLB bioStep Co., Ltd.
HLB bioStep Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Provides clinical research services | Commercial Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.